It remains poorly understood how the haematopoietic stem/progenitor cells (HSPC) are attracted to their niches and the functional consequences of such interaction. In the present study, we show that the cell cycle regulator cyclin A1 in association with vascular endothelial growth factor receptor 1 (VEGFR1), is required for HSPC and their niches to maintain their function and proper interaction. In the absence of cyclin A1, the HSPC in the BM are increased in their frequency and display an increased migratory and homing ability. Concomitantly, the ability of the endosteal and central BM niche zones to attract and home the wild-type HSPC is significantly reduced in cyclin A1-null mice as compared to the wild-type controls. The impaired proliferation and homing of HSPC in the BM of cyclin A1-null mice are attributed to the increased density of microvessels in the endosteal and central BM niche zones, which is associated with the increased VEGFR1 expression. Thus, modulation of cyclin A1 and VEGFR1 in HSPC and their niches may provide new insights into therapeutic approaches.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614519PMC
http://dx.doi.org/10.1080/15384101.2015.1026513DOI Listing

Publication Analysis

Top Keywords

hspc niches
8
endosteal central
8
central niche
8
niche zones
8
cyclin a1-null
8
a1-null mice
8
cyclin
6
hspc
6
cyclin regulates
4
regulates interactions
4

Similar Publications

Epigenetic regulation in hematopoietic stem cells (HSCs) research has emerged as a transformative molecular approach that enhances understanding of hematopoiesis and hematological disorders. This chapter investigates the intricate epigenetic mechanisms that control HSCs function, including deoxyribonucleic acid (DNA) methylation, histone modifications, and chromatin remodeling. It also explores the role of non-coding ribonucleic acid (RNAs) as epigenetic regulators, highlighting how changes in gene expression can occur without alterations to the DNA sequence.

View Article and Find Full Text PDF

Somatic mutations in hematopoietic stem/progenitor cells (HSPCs) can lead to clonal hematopoiesis of indeterminate potential (CHIP), potentially progressing to myelodysplastic syndromes (MDS). Here, we investigated how CHIP and MDS remodel the human bone marrow (BM) niche relative to healthy elderly donors, using single cell and anatomical analyses in a large BM cohort. We found distinct inflammatory remodeling of the BM in CHIP and MDS.

View Article and Find Full Text PDF

ERRα is dispensable for hematopoietic stem cell function in the bone marrow.

Biochem Biophys Res Commun

December 2024

Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea; Transplantation Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, 50612, Republic of Korea. Electronic address:

Hematopoietic stem cells (HSCs) have the ability to self-renew, differentiate into various blood cell types, and reside in the bone marrow (BM) niche. Estrogen-related receptor α (ERRα) is an orphan nuclear receptor that has a role in mitochondrial biogenesis and metabolic regulation. Previous research has shown that ERRα contributes to the development of acute myeloid leukemia (AML) by acting as a key regulator of mitochondrial processes, though its role in HSC regulation remains mostly unknown.

View Article and Find Full Text PDF

Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche.

Exp Hematol

November 2024

Center for Integrative Medicine and Physics, Institute for Advances Study, Kyoto University, Kyoto, Japan; Physical Chemistry of Biosystems, Institute of Physical Chemistry, Heidelberg University, Heidelberg, Germany. Electronic address:

The present knowledge on hematopoietic stem and progenitor cell (HSPC) biology and aging is based largely on studies in mouse models. Although mouse models are invaluable, they are not without limitations for defining how physical properties of HSPCs and their niche change with age. The bone marrow (BM) niche is a complex, interactive environment with multiple cell types.

View Article and Find Full Text PDF
Article Synopsis
  • - Current hematology studies often use immunodeficient mouse models to test patient-derived stem cells, but these models struggle with effectively incorporating cells from patients with myelodysplastic syndromes (MDS).
  • - Researchers created a new bone marrow organoid model from induced pluripotent stem cells (iPSCs) that accurately mimics the human bone marrow environment, improving the engraftment of MDS patient stem cells and reflecting their unique disease traits.
  • - The organoid model demonstrated that stem cells from both normal donors and MDS patients could proliferate and maintain their characteristics in a supportive microenvironment, revealing distinct differentiation patterns that correlate with MDS's clinical features and opening up possibilities for personalized treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!